HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joseph H Friedman Selected Research

pimavanserin

1/2022Long-term outcomes with pimavanserin for psychosis in clinical practice.
11/2018Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.
9/2018Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review.
1/2018Pharmacological interventions for psychosis in Parkinson's disease patients.
7/2017A Retrospective Study of Pimavanserin Use in a Movement Disorders Clinic.
8/2014Treating psychosis in movement disorder patients: a review.
10/2013Pimavanserin for the treatment of Parkinson's disease psychosis.
3/2010Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joseph H Friedman Research Topics

Disease

49Parkinson Disease (Parkinson's Disease)
07/2022 - 01/2002
33Psychotic Disorders (Schizoaffective Disorder)
07/2022 - 01/2002
19Parkinsonian Disorders (Parkinsonism)
10/2021 - 03/2004
14Movement Disorders (Movement Disorder)
07/2022 - 06/2002
11Tremor (Tremors)
07/2022 - 09/2002
10Dementia (Dementias)
10/2021 - 06/2002
8Dyskinesias (Dyskinesia)
07/2022 - 01/2003
8Schizophrenia (Dementia Praecox)
09/2018 - 01/2002
7Tardive Dyskinesia
01/2021 - 01/2004
7Fatigue
01/2020 - 01/2003
6Hallucinations (Hallucination)
03/2016 - 01/2002
4Agranulocytosis (Granulocytopenia)
07/2022 - 01/2003
4Huntington Disease (Huntington's Disease)
01/2017 - 06/2012
3Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
01/2021 - 12/2015
3Ataxia (Dyssynergia)
01/2021 - 10/2020
3Disease Progression
01/2019 - 05/2014
3Stroke (Strokes)
09/2018 - 08/2006
2Essential Tremor (Essential Tremors)
01/2021 - 01/2015
2Sleep Initiation and Maintenance Disorders (Insomnia)
08/2019 - 04/2014
2Cognitive Dysfunction
11/2018 - 08/2010
2REM Sleep Behavior Disorder
04/2014 - 02/2007
2Hypotension (Low Blood Pressure)
03/2010 - 01/2003
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Torticollis (Wryneck)
01/2021
1Brain Diseases (Brain Disorder)
01/2021
1Multiple System Atrophy
01/2021
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2021
1Psychomotor Agitation (Akathisia)
10/2020
1Serotonin Syndrome (Syndrome, Serotonin)
10/2020
1Myoclonus (Nocturnal Myoclonus)
10/2020
1Bipolar Disorder (Manic Depressive Psychosis)
08/2019
1Hereditary Spastic Paraplegia
10/2018
1Drug-Related Side Effects and Adverse Reactions
01/2018
1Synucleinopathies
07/2017
1Dystonia (Limb Dystonia)
12/2015
1Hypokinesia (Bradykinesia)
05/2014
1Sialorrhea
04/2014
1Weight Loss (Weight Reduction)
04/2014
1Gout
02/2014
1Urolithiasis
02/2014
1Anhedonia
07/2013
1Fungal Meningitis
01/2013
1Back Pain (Backache)
01/2013

Drug/Important Bio-Agent (IBA)

30Antipsychotic Agents (Antipsychotics)IBA
07/2022 - 01/2002
19Pharmaceutical PreparationsIBA
10/2020 - 01/2002
12Clozapine (Clozaril)FDA LinkGeneric
07/2022 - 01/2003
9Levodopa (L Dopa)FDA LinkGeneric
07/2022 - 06/2002
8pimavanserinIBA
01/2022 - 03/2010
7Dopamine Receptors (Dopamine Receptor)IBA
10/2020 - 01/2003
5Quetiapine Fumarate (Seroquel)FDA Link
01/2018 - 06/2002
4Aripiprazole (Abilify)FDA Link
01/2021 - 01/2004
3Valproic Acid (Depakote)FDA LinkGeneric
01/2021 - 02/2006
3Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA
01/2019 - 12/2002
3Dopamine Agonists (Dopamine Agonist)IBA
06/2013 - 01/2010
3Olanzapine (Zyprexa)FDA Link
12/2011 - 09/2002
2Biomarkers (Surrogate Marker)IBA
01/2021 - 12/2014
2Ataxin-3IBA
01/2021 - 10/2020
2polyglutamineIBA
01/2021 - 10/2020
2Biological ProductsIBA
10/2020 - 02/2014
2valbenazineIBA
01/2020 - 01/2019
25-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
11/2018 - 03/2010
2coenzyme Q10 (CoQ10)IBA
01/2017 - 05/2014
2Medical MarijuanaIBA
11/2014 - 06/2012
2rotigotineFDA Link
01/2014 - 07/2013
2Risperidone (Risperdal Consta)FDA LinkGeneric
01/2003 - 01/2002
1neodymium pyrocatechin disulfonate (NPD)IBA
10/2021
1Proteins (Proteins, Gene)FDA Link
10/2020
1Anticonvulsants (Antiepileptic Drugs)IBA
10/2020
1Antidepressive Agents (Antidepressants)IBA
10/2020
1BenzodiazepinesIBA
10/2020
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
10/2020
1Serotonin (5 Hydroxytryptamine)IBA
10/2020
1LithiumIBA
10/2020
1deutetrabenazineIBA
01/2019
1Cholinergic Agents (Cholinergics)IBA
11/2018
1rasagiline (Azilect)FDA Link
01/2017
1Botulinum Toxins (Botulinum Toxin)IBA
12/2015
1ioflupaneIBA
02/2015
1Phosphoric Diester Hydrolases (Phosphodiesterases)IBA
12/2014
1Amantadine (Aman)FDA LinkGeneric
09/2014
1AntioxidantsIBA
05/2014
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
04/2014
1Mirtazapine (Rexer)FDA LinkGeneric
04/2014
1Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
04/2014
1Clonazepam (Rivotril)FDA LinkGeneric
04/2014
1Uric Acid (Urate)IBA
02/2014
1InosineFDA Link
02/2014
1dimemorfan (AT 17)IBA
01/2014
1Dihydrotachysterol (AT 10)IBA
12/2013
1Crack CocaineIBA
06/2013
1SteroidsIBA
01/2013

Therapy/Procedure

8Therapeutics
10/2020 - 05/2004
6Home Nursing (Nursing, Home)
12/2014 - 01/2002
2Gastrostomy
10/2021 - 01/2021
2Activities of Daily Living (ADL)
01/2020 - 09/2002
1Exercise Therapy (Therapy, Exercise)
01/2022
1Institutionalization (Institutionalized Persons)
11/2019
1Bariatric Surgery
01/2016
1Aftercare (After-Treatment)
12/2015
1Epidural Injections
01/2013